What does Genetics Generation Advancement Corp. do?

Genetics Generation Advancement Corp. (4160.TWO) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4160.TWO's market cap?

Genetics Generation Advancement Corp. (4160.TWO) has a market capitalization of approximately $1.06 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 4160.TWO pay a dividend?

Yes — Genetics Generation Advancement Corp. (4160.TWO) pays a dividend annually, with a trailing-twelve-month yield of 4.66%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

4160.TWO

Genetics Generation Advancement Corp.

TWO·Medical, Diagnostics & Research · Healthcare

NT$39.60NT$0.10−0.25%

Market capNT$1.06B·Aug 26 5:30 AM UTC

Price Chart

NT$39.60−NT$0.10 (−0.25%)today

+76.86%CAGR +12.08%

Select date range

FromTo

Jul 15, 2011Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)4.66%

Annual Dividend (FWD)NT$1.85

Dividend Growth (5Y)+24.5%

Dividend Safety—

Payout Ratio230.9%

FCF Payout Ratio—

Most Recent DividendNT$1.85

Ex-Dividend DateOct 3

Payment DateOct 31

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−43.6%

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateFeb 26

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$614.42M

Net IncomeNT$17.98M

Net Margin2.9%

Operating Cash Flow−NT$140.00K

Capital ExpendituresNT$35.76M

Free Cash Flow−NT$35.90M

Return on Equity3.6%

Return on Invested Capital0.0%

Net CashNT$194.27M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4160.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4160.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4160.TWO and 80,000+ other tickers.

About Genetics Generation Advancement Corp.

Genetics Generation Advancement Corp. (GGAC), headquartered in Taipei, Taiwan, specializes in providing advanced genetic testing and bioinformatics solutions. The company serves a diverse global clientele across Taiwan, Asia, Europe, and the Americas. GGAC offers a comprehensive array of genetic screenings tailored for various life stages and health needs. These include pre-conception, prenatal, and newborn testing, in addition to adult health management, cancer predisposition, and pharmacogenetic analyses. The company also collaborates with and provides services to institutional partners…

CEO: Qing Yuan Kang
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: TWO
Employees: 169
Website: www.gga.asia

Peers

Peers Tab

6645.TW

Kim Forest Enterprise Co., Ltd.

Cap

NT$785.1M

6730.TWO

Lagis Enterprise Co., Ltd.

Cap

NT$1.2B

4161.TWO

Bioptik Technology Incorporation

Cap

NT$1.4B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4160.TWO

What does Genetics Generation Advancement Corp. do?: Genetics Generation Advancement Corp. (4160.TWO) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4160.TWO's market cap?: Genetics Generation Advancement Corp. (4160.TWO) has a market capitalization of approximately $1.06 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 4160.TWO pay a dividend?: Yes — Genetics Generation Advancement Corp. (4160.TWO) pays a dividend annually, with a trailing-twelve-month yield of 4.66%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.